BOULDER, Colo., Nov. 8, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: www.arraybiopharma.com.
Event: Stifel 2016 Healthcare Conference Date: Tuesday, November 15, 2016 Time: 10:15 a.m. Eastern Standard Time Event: Jefferies 2016 Global Healthcare Conference Date: Thursday, November 17, 2016 Time: 5:20 p.m. Greenwich Mean Time
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to http://www.arraybiopharma.com/.
CONTACT: Tricia Haugeto Array BioPharma Inc. 303-386-1193 thaugeto@arraybiopharma.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-stifel-2016-healthcare-and-jefferies-2016-global-healthcare-conferences-300359249.html
SOURCE Array BioPharma Inc.